18F-FDG PET/CT radiomics for distinguishing LUAD from LUSC in non-small cell lung cancer

18F-FDG PET/CT 放射组学用于区分非小细胞肺癌中的肺腺癌和肺鳞癌

阅读:1

Abstract

BACKGROUND: This study evaluates the effectiveness of radiomics based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in distinguishing lung adenocarcinoma from squamous cell carcinoma, the 2 major subtypes of non-small cell lung cancer (NSCLC). METHODS: We extracted radiomic features from both the intratumoral and peritumoral areas in NSCLC patients' PET/CT scans. The intratumoral volume of interest (VOI_I) was manually outlined on PET/CT images. Additionally, 4 peritumoral VOIs (VOI_P) were automatically generated by expanding VOI_I by 1, 2, 3, and 4 mm. A total of 107 radiomic features were extracted from each VOI. Feature selection was conducted using the t test, Spearman correlation analysis, and the least absolute shrinkage and selection operator. Subsequently, radiomics models (VOI_I model, VOI_P model, and a combined model) were constructed. The models' performance was assessed by the area under the curve (AUC). RESULTS: In the training set, the intratumoral (VOI_PET_I) model achieved the highest AUC (0.973), followed by the peritumoral 1 mm (VOI_PET_P1) model (AUC = 0.952). However, in the independent testing set, the VOI_PET_P1 model outperformed the VOI_PET_I model, achieving the highest AUC of 0.931 versus 0.920, respectively. This suggests that the peritumoral 1 mm region may provide superior generalizability for subtype classification in unseen data. CONCLUSION: In this study, radiomics features extracted from both intratumoral and peritumoral regions on 18F-FDG PET/CT demonstrated high predictive value for classifying NSCLC pathological subtypes. Notably, the 1 mm peritumoral region exhibited the best performance for differentiating lung adenocarcinomas, especially in the independent testing cohort. However, these findings are based on a single-center cohort with a limited sample size and require further validation in larger, multicenter studies to confirm their clinical utility and generalizability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。